Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...

Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...

The 84-year-old Navy veteran, whose real name is Kenny Jary, boasts over 4 million followers across social media platforms ...

Leah Phillips, a Kentucky mom of three, said she was initially told her symptoms were due to a cold, allergies or anxiety ...

Boehringer Ingelheim today announced that The New England Journal of Medicine (NEJM) published results from the Phase 1b Beamion LUNG-1 trial of HERNEXEOS (zongertinib tablets) in ...

A shared decision-making aid can be beneficial during the treatment process for patients with lung cancer, according to a ...

Dr Christine Bestvina discusses EGFR treatment shifts, KRAS trial data, and expanding clinical trial access for community oncologists. Lung cancer treatment has undergone a remarkable transformation ...

The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...

First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...

ESPN’s Dick Vitale, 86, faces his fifth cancer as melanoma spreads to the lung and liver. He remains optimistic, highlighting ...

Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious ...